These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 6130330)

  • 21. [Prostaglandins including prostacyclin in the treatment of peripheral arterial occlusive disorders].
    Alexander K
    Internist (Berl); 1989 Jul; 30(7):429-39. PubMed ID: 2670810
    [No Abstract]   [Full Text] [Related]  

  • 22. Successful therapy of advanced arteriosclerosis obliterans with prostacyclin.
    Szczeklik A; Nizankowski R; Skawinski S; Szczeklik J; Gluszko P; Gryglewski RJ
    Lancet; 1979 May; 1(8126):1111-4. PubMed ID: 86835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of prostaglandin E1 in the treatment of lower extremity ischemic ulcers secondary to peripheral vascular occlusive disease. Results of a prospective randomized, double-blind, multicenter clinical trial.
    Schuler JJ; Flanigan DP; Holcroft JW; Ursprung JJ; Mohrland JS; Pyke J
    J Vasc Surg; 1984 Jan; 1(1):160-70. PubMed ID: 6384558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolonged infusion of prostacyclin in patients with advanced stages of peripheral vascular disease: a placebo-controlled cross-over study.
    Hossmann V; Auel H; Rücker W; Schrör K
    Klin Wochenschr; 1984 Dec; 62(23):1108-14. PubMed ID: 6394890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prostacyclin in treatment of peripheral vascular disease of lower extremities (author's transl)].
    Szczeklik A; Głusko P; Gryglewski R; Szczeklik J; Kostka-Trabka E; Grodzińska L; Nizanowski R; Dembińska-Kieć A; Skawiński S; Bieroń K; Billewicz O; Telesz E
    Przegl Lek; 1980; 37(9):659-62. PubMed ID: 6106960
    [No Abstract]   [Full Text] [Related]  

  • 26. Pilot study of the effects of taprostene (CG 4203) in patients with advanced peripheral arterial disease.
    Darius H; Kopp H; Mulfinger A; Spielberger M; Todt M; Schuster CJ; Meyer J
    Prog Clin Biol Res; 1989; 301():417-21. PubMed ID: 2508112
    [No Abstract]   [Full Text] [Related]  

  • 27. [Iloprost, a stable prostacyclin derivative, in stage 4 arterial occlusive disease. A placebo-controlled multicenter study].
    Diehm C; Abri O; Baitsch G; Bechara G; Beck K; Breddin HK; Brock FE; Clevert HD; Corovic D; Marshall M
    Dtsch Med Wochenschr; 1989 May; 114(20):783-8. PubMed ID: 2470569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostacyclin in peripheral arterial occlusive disease (PAOD): clinical and hemodynamic findings in patients with PAOD stage III and IV.
    Valentin A; Karnik R; Sehnal E; Slany J
    Prog Clin Biol Res; 1987; 242():457-62. PubMed ID: 3313420
    [No Abstract]   [Full Text] [Related]  

  • 29. Epoprostenol sodium (prostacyclin) infusion in acute myocardial infarction.
    Kiernan FJ; Kluger J; Regnier JC; Rutkowski M; Fieldman A
    Br Heart J; 1986 Nov; 56(5):428-32. PubMed ID: 3539163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous prostacyclin (PGI2) infusion to 108 patients with ischaemic peripheral vascular disease: phase II-open study.
    Virgolini I; Fitscha P; Weiss K; Linet OI; O'Grady J; Sinzinger H
    Prostaglandins; 1991 Jul; 42(1):9-14. PubMed ID: 1771241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treprostinil sodium (Remodulin), a prostacyclin analog, in the treatment of critical limb ischemia: open-label study.
    Berman S; Quick R; Yoder P; Voigt S; Strootman D; Wade M
    Vascular; 2006; 14(3):142-8. PubMed ID: 16956486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of ciprostene in patients with peripheral vascular disease (PVD) characterized by ischemic ulcers. The Ciprostene Study Group.
    J Clin Pharmacol; 1991 Jan; 31(1):81-7. PubMed ID: 2045533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preliminary experience with prostaglandins E1 and I2 in peripheral vascular disease.
    Pardy BJ; Lewis JD; Eastcott HH
    Surgery; 1980 Dec; 88(6):826-32. PubMed ID: 7003784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of effect of i.v. prostacyclin on aspirin-induced asthma.
    Nizankowska E; Czerniawska-Mysik G; Szczeklik A
    Eur J Respir Dis; 1986 Nov; 69(5):363-8. PubMed ID: 3539632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epoprostenol and severe arterial disease.
    Olsson AG
    Lancet; 1983 Mar; 1(8326 Pt 1):711-2. PubMed ID: 6132070
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of peripheral arterial disease with prostacyclin. I. Effect of prostacyclin on the healing of ischemic ulcers of the lower extremities].
    Nizankowski R
    Kardiol Pol; 1986; 29(3):209-17. PubMed ID: 3534429
    [No Abstract]   [Full Text] [Related]  

  • 37. Two randomised and placebo-controlled studies of an oral prostacyclin analogue (Iloprost) in severe leg ischaemia. The Oral Iloprost in severe Leg Ischaemia Study Group.
    Eur J Vasc Endovasc Surg; 2000 Oct; 20(4):358-62. PubMed ID: 11038148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluation of the analgesic effect of naftidrofuryl in permanent ischemia in patients with arterial diseases. Double-blind versus placebo study].
    Testart J; Guidicelli H; Glanddier G; Mosnier M
    Ann Cardiol Angeiol (Paris); 1994 Nov; 43(9):542-7. PubMed ID: 7864561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostacyclin in the treatment of painful Peyronie's disease.
    Strachan JR; Pryor JP
    Br J Urol; 1988 Jun; 61(6):516-7. PubMed ID: 3042083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostacyclin infusion in patients with acute myocardial infarction.
    Henriksson P; Edhag O; Wennmalm A
    Br Heart J; 1985 Feb; 53(2):173-9. PubMed ID: 2857087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.